Bio-Rad Laboratories [BIO] vs Masimo [MASI] Detailed Stock Comparison

Bio-Rad Laboratories Inc.

NYSE
Loading...

Masimo Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bio-Rad Laboratories Inc. wins in 13 metrics, Masimo Corporation wins in 7 metrics, with 0 ties. Bio-Rad Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bio-Rad Laboratories Inc. Masimo Corporation Better
P/E Ratio (TTM) 10.98 46.47 Bio-Rad Laboratories Inc.
Price-to-Book Ratio 1.11 12.89 Bio-Rad Laboratories Inc.
Debt-to-Equity Ratio 18.58 77.55 Bio-Rad Laboratories Inc.
PEG Ratio -0.05 27.03 Masimo Corporation
EV/EBITDA 18.75 28.15 Bio-Rad Laboratories Inc.
Profit Margin (TTM) 29.42% -9.92% Bio-Rad Laboratories Inc.
Operating Margin (TTM) 8.87% 18.52% Masimo Corporation
EBITDA Margin (TTM) 8.87% 18.52% Masimo Corporation
Return on Equity 10.84% 23.43% Masimo Corporation
Return on Assets (TTM) 1.67% 8.86% Masimo Corporation
Free Cash Flow (TTM) $374.60M $193.10M Bio-Rad Laboratories Inc.
1-Year Return 26.01% 11.63% Bio-Rad Laboratories Inc.
Price-to-Sales Ratio (TTM) 3.20 6.12 Bio-Rad Laboratories Inc.
Enterprise Value $8.09B $9.72B Masimo Corporation
EV/Revenue Ratio 3.13 6.37 Bio-Rad Laboratories Inc.
Gross Profit Margin (TTM) 49.80% 59.95% Masimo Corporation
Revenue per Share (TTM) $95 $28 Bio-Rad Laboratories Inc.
Earnings per Share (Diluted) $27.85 $3.84 Bio-Rad Laboratories Inc.
Beta (Stock Volatility) 1.16 1.20 Bio-Rad Laboratories Inc.
Short % of Float 0.00% 6.81% Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. vs Masimo Corporation Stock Performance Analysis

Loading Price Chart...

BIO
MASI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bio-Rad Laboratories Inc.1.17%-0.70%16.87%10.73%-6.05%-5.24%
Masimo Corporation0.00%0.63%0.78%2.54%30.08%41.25%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bio-Rad Laboratories Inc.26.01%-24.07%-54.09%102.91%143.91%328.31%
Masimo Corporation11.63%11.44%-25.04%256.34%498.24%798.85%

Performance & Financial Health Analysis: Bio-Rad Laboratories Inc. vs Masimo Corporation

MetricBIOMASI
Market Information
Market Cap i$7.60B$9.36B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i239,625558,463
90 Day Avg. Volume i284,7851,362,548
Last Close$289.28$179.95
52 Week Range$222.80 - $343.12$125.94 - $179.99
% from 52W High-15.69%-0.02%
All-Time High$832.70 (Aug 30, 2021)$305.21 (Nov 15, 2021)
% from All-Time High-65.26%-41.04%
Growth Metrics
Quarterly Revenue Growth0.04%0.12%
Quarterly Earnings Growth0.04%N/A
Financial Health
Profit Margin (TTM) i0.29%-0.10%
Operating Margin (TTM) i0.09%0.19%
Return on Equity (TTM) i0.11%0.23%
Debt to Equity (MRQ) i18.5877.55
Cash & Liquidity
Book Value per Share (MRQ)$276.16$13.84
Cash per Share (MRQ)$57.08$2.92
Operating Cash Flow (TTM) i$532.20M$217.80M
Levered Free Cash Flow (TTM) i$256.55M$316.41M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Bio-Rad Laboratories Inc. vs Masimo Corporation

MetricBIO (Apr 24, 2026)MASI (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.9846.47
Forward P/E i26.9427.03
PEG Ratio i-0.0527.03
Price to Sales (TTM) i3.206.12
Price to Book (MRQ) i1.1112.89
Market Capitalization
Market Capitalization i$7.60B$9.36B
Enterprise Value i$8.09B$9.72B
Enterprise Value Metrics
Enterprise to Revenue i3.136.37
Enterprise to EBITDA i18.7528.15
Risk & Other Metrics
Beta i1.161.20
Book Value per Share (MRQ) i$276.16$13.84

Financial Statements Comparison: Bio-Rad Laboratories Inc. vs Masimo Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBIO (2025)MASI (2025)
Revenue/Sales i2.58B1.53B
Cost of Goods Sold i1.24B581.70M
COGS % of Revenue i48.1%38.1%
Gross Profit i1.34B945.20M
Gross Margin i51.9%61.9%
Research & Development i275.60M126.40M
Operating Income (EBIT) i218.60M312.80M
Operating Margin i8.5%20.5%
EBITDA i480.70M355.00M
EBITDA Margin i18.6%23.2%
Pre-Tax Income i995.50M272.60M
Pre-Tax Income % of Revenue i38.5%17.9%
Income Tax i235.60M64.90M
Income Tax % of Revenue i9.1%4.3%
Net Income (Profit) i759.90M-151.50M
Profit Margin i29.4%-9.9%

Balance Sheet & Liquidity Metrics

MetricBIO (2025)MASI (2025)
Cash & Equivalents i529.80M152.30M
Total Current Assets i2.91B926.00M
Total Current Assets % of Revenue i112.5%60.6%
Total Current Liabilities i517.00M371.60M
Total Current Liabilities % of Revenue i20.0%24.3%
Long-Term Debt i1.35B544.90M
Long-Term Debt % of Revenue i52.2%35.7%
Total Shareholders Equity i7.45B721.20M
Retained Earnings i8.18B1.34B
Retained Earnings % of Revenue i316.5%87.7%
Property, Plant & Equipment i1.49B237.20M

Cash Flow Statement Comparison

MetricBIO (2025)MASI (2025)
Operating Cash Flow i1.25B198.40M
Operating Cash Flow % of Revenue i48.4%13.0%
Capital Expenditures i-157.50M200,000
Free Cash Flow i374.60M193.10M
FCF Margin i14.5%12.6%
Debt Repayment i-500,000-1.28B
Common Stock Repurchase i-295.50M-363.70M

Short Interest & Institutional Ownership Analysis

MetricBIOMASI
Shares Short i263.25M
Short Ratio i0.001.68
Short % of Float i0.00%6.81%
Shares Outstanding i26.99M52.10M
Float Shares i21.13M47.45M
% Held by Insiders i16.20%5.00%
% Held by Institutions i91.50%109.04%
% Held by Public i-7.70%-14.04%

Dividend Analysis & Yield Comparison: Bio-Rad Laboratories Inc. vs Masimo Corporation

MetricBIOMASI
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A